Michael R. Abern

1.2k total citations
37 papers, 870 citations indexed

About

Michael R. Abern is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Michael R. Abern has authored 37 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 9 papers in Urology. Recurrent topics in Michael R. Abern's work include Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (12 papers) and Renal cell carcinoma treatment (8 papers). Michael R. Abern is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (12 papers) and Renal cell carcinoma treatment (8 papers). Michael R. Abern collaborates with scholars based in United States, France and Italy. Michael R. Abern's co-authors include Laurence A. Levine, Matvey Tsivian, Thomas J. Polascik, Brant A. Inman, Richmond Owusu, Stephen M. Larsen, Christopher L. Coogan, Stephen J. Freedland, Annie Dude and Christopher L. Amling and has published in prestigious journals such as The Journal of Urology, BioMed Research International and Urology.

In The Last Decade

Michael R. Abern

37 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael R. Abern United States 19 411 364 195 188 180 37 870
Gianni Vittori Italy 18 611 1.5× 357 1.0× 357 1.8× 105 0.6× 143 0.8× 59 983
Geoffrey N. Sklar United States 15 406 1.0× 207 0.6× 119 0.6× 135 0.7× 164 0.9× 32 834
Gregory Joice United States 16 398 1.0× 340 0.9× 185 0.9× 60 0.3× 85 0.5× 57 799
Dayron Rodríguez United States 19 278 0.7× 392 1.1× 118 0.6× 64 0.3× 177 1.0× 49 933
H.J.A. Mensink Netherlands 14 592 1.4× 183 0.5× 197 1.0× 102 0.5× 122 0.7× 35 1.0k
JEFF A. WIEDER United States 12 754 1.8× 216 0.6× 215 1.1× 61 0.3× 97 0.5× 18 946
Antônio Carlos Lima Pompeo Brazil 19 584 1.4× 297 0.8× 188 1.0× 37 0.2× 203 1.1× 71 1.2k
Koji Mita Japan 16 313 0.8× 201 0.6× 130 0.7× 23 0.1× 168 0.9× 62 606
Jairam R. Eswara United States 15 207 0.5× 344 0.9× 321 1.6× 27 0.1× 181 1.0× 47 974
Jason Stasi United States 17 607 1.5× 762 2.1× 158 0.8× 176 0.9× 59 0.3× 31 1.1k

Countries citing papers authored by Michael R. Abern

Since Specialization
Citations

This map shows the geographic impact of Michael R. Abern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Abern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Abern more than expected).

Fields of papers citing papers by Michael R. Abern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Abern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Abern. The network helps show where Michael R. Abern may publish in the future.

Co-authorship network of co-authors of Michael R. Abern

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Abern. A scholar is included among the top collaborators of Michael R. Abern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Abern. Michael R. Abern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schlicht, Michael J., et al.. (2021). Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids. iScience. 24(6). 102640–102640. 3 indexed citations
3.
Vigneswaran, Hari T., et al.. (2020). Ethnic variation in prostate cancer detection: A hypothesis generating study for use of the Stockholm3 test in an American cohort. European Urology Open Science. 19. e260–e261. 2 indexed citations
4.
Tan, Wei Phin, Kalyan C. Latchamsetty, Nathaniel R. Wilson, et al.. (2018). Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy. Prostate Cancer and Prostatic Diseases. 22(2). 268–275. 7 indexed citations
5.
Abern, Michael R., William J. Aronson, Christopher J. Kane, et al.. (2014). PD31-07 AGENT ORANGE AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY. The Journal of Urology. 191(4S). 1 indexed citations
6.
Tsivian, Matvey, et al.. (2014). Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans. Urologic Oncology Seminars and Original Investigations. 32(5). 555–560. 8 indexed citations
7.
Allott, Emma H., Michael R. Abern, Lukas C. Gerber, et al.. (2013). Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database. Prostate Cancer and Prostatic Diseases. 16(4). 391–397. 46 indexed citations
8.
Abern, Michael R., Matvey Tsivian, Christopher L. Coogan, Howard L. Kaufman, & Thomas J. Polascik. (2013). Characteristics of patients diagnosed with both melanoma and renal cell cancer. Cancer Causes & Control. 24(11). 1925–1933. 8 indexed citations
9.
Abern, Michael R., Richmond Owusu, & Brant A. Inman. (2013). Clinical performance and utility of a DNA methylation urine test for bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(1). 51.e21–51.e26. 22 indexed citations
10.
Ross, Sherry S., Elizabeth M. Masko, Michael R. Abern, et al.. (2013). The Effect of Dietary Sodium and Fructose Intake on Urine and Serum Parameters of Stone Formation in a Pediatric Mouse Model: A Pilot Study. The Journal of Urology. 190(4S). 1484–1489. 6 indexed citations
11.
Tsivian, Matvey, et al.. (2013). Short-term Functional Outcomes and Complications Associated With Transperineal Template Prostate Mapping Biopsy. Urology. 82(1). 166–170. 24 indexed citations
12.
Tsivian, Matvey, Michael R. Abern, Lionel L. Bañez, et al.. (2012). Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5–4 ng/ml. Urologic Oncology Seminars and Original Investigations. 31(8). 1527–1532. 4 indexed citations
13.
Abern, Michael R., Lionel L. Bañez, Thomas J. Polascik, et al.. (2012). Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center. Prostate Cancer and Prostatic Diseases. 16(1). 85–90. 65 indexed citations
14.
Abern, Michael R., Matvey Tsivian, & Thomas J. Polascik. (2012). Focal Therapy of Prostate Cancer: Evidence-based Analysis for Modern Selection Criteria. Current Urology Reports. 13(2). 160–169. 16 indexed citations
15.
Abern, Michael R., Annie Dude, Matvey Tsivian, & Christopher L. Coogan. (2012). The characteristics of bladder cancer after radiotherapy for prostate cancer. Urologic Oncology Seminars and Original Investigations. 31(8). 1628–1634. 44 indexed citations
16.
Abern, Michael R., William J. Aronson, Martha K. Terris, et al.. (2012). Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database. The Prostate. 73(4). 409–417. 73 indexed citations
17.
Taylor, Frederick L., Michael R. Abern, & Laurence A. Levine. (2011). Predicting Erectile Dysfunction Following Surgical Correction of Peyronie’s Disease Without Inflatable Penile Prosthesis Placement: Vascular Assessment and Preoperative Risk Factors. The Journal of Sexual Medicine. 9(1). 296–301. 35 indexed citations
18.
Abern, Michael R., Stephen M. Larsen, & Laurence A. Levine. (2011). Combination of Penile Traction, Intralesional Verapamil, and Oral Therapies for Peyronie’s Disease. The Journal of Sexual Medicine. 9(1). 288–295. 97 indexed citations
19.
Abern, Michael R., Annie Dude, & Christopher L. Coogan. (2010). Marital status independently predicts testis cancer survival—an analysis of the SEER database. Urologic Oncology Seminars and Original Investigations. 30(4). 487–493. 30 indexed citations
20.
Abern, Michael R. & Laurence A. Levine. (2009). Peyronie's Disease: Evaluation and Review of Nonsurgical Therapy. The Scientific World JOURNAL. 9. 665–675. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianni Vittori Breakdown of academic impact, for papers by Geoffrey N. Sklar Breakdown of academic impact, for papers by Gregory Joice Breakdown of academic impact, for papers by Dayron Rodríguez Breakdown of academic impact, for papers by H.J.A. Mensink Breakdown of academic impact, for papers by JEFF A. WIEDER Breakdown of academic impact, for papers by Antônio Carlos Lima Pompeo Breakdown of academic impact, for papers by Koji Mita Breakdown of academic impact, for papers by Jairam R. Eswara Breakdown of academic impact, for papers by Jason Stasi
Rankless by CCL
2026